| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.005 |